Apotex Inc. v. United States of America
Apotex Inc., a Canadian pharmaceuticals corporation, alleges that U.S. courts and administrative agencies committed errors in interpreting federal law, and that such errors are in violation of NAFTA Article 1102 (national treatment) and Article 1105 (minimum standard of treatment under international law). Apotex also alleges that the challenged U.S. court and agency decisions expropriated Apotex’s investments under NAFTA Article 1110.
The United States intends to defend this claim vigorously.
-06/04/09
Notice of Arbitration
[1080 Kb]
The Office of Electronic Information, Bureau of Public Affairs, manages this site as a portal for information from the U.S. State Department. External links to other Internet sites should not be construed as an endorsement of the views or privacy policies contained therein.